10-11 January 2017, 'Engineering for clinical success': CHI's 4th annual Antibody Drug Conjugates conference, San Diego

20-22 September 2017, 8th World ADC, San Diego

20-22 February 2017, World ADC Europe, Berlin

November 18, 2016: MedChem2016, Annual One-Day Meeting on Medicinal Chemistry in Mont-Saint-Guibert, Belgium. Tagworks CEO Marc Robillard will present the company's recent progress in technology development and applications. Conference theme: PET & Imaging, From Chemistry Lab to Clinical Applications. More information: MedChem2016 conference

October 3-4, 2016: FIGON Dutch Medicines Days, Ede, The Netherlands. Tagworks CEO Marc Robillard will present the company's technology and applications on October 3, during the session on Medicinal Chemistry. More information: http://www.figondmd.nl 

December 6-8, 2016: CHAINS 2016, Veldhoven, The Netherlands. More information: http://www.nwochains.nl

December 11-15, 2016: Antibody Engineering & Therapeutics, San Diego. More information: https://lifesciences.knect365.com/antibody-engineering-therapeutics/

October 10-13, 2016: 7th World ADC San Diego conference. More information: http://worldadc-usa.com

In a recent publication in the scientific journal Bioconjugate Chemistry, Tagworks Pharma describes its success in using a bioorthogonal reaction for the selective cleavage of tumor-bound ADCs in mice. This represents a powerful new tool for ADC therapy as it does not rely on the currently used biological activation mechanisms, …

On Thursday September 1, 2016, Tagworks' CEO Marc Robillard will present the company's technology in the In Vivo Chemistry-session during the EFMC International Symposium on Medicinal Chemistry in Manchester (Aug 28 - Sep 1).